ClinicalTrials.gov
public full text
Public Domain
Evaluating the Neuromodulatory Effect of Ketamine in Long COVID-19
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- BCAAs in Concussion 2.0#896582
- Ketamine, propofol and the EEG: A neural field analysis of HCN1-mediated interactions#1005272
- Intranasal Ketamine in Ultra-REsistant Depression (SURE-ECT Non Responders)#373675
- Adding Ketamine to Levobupivacaine in Paravertebral Block in Thoracotomy#841090
- Intranasal delivery of dodecyl creatine ester alleviates motor deficits and increases dopamine levels in a 6-OHDA rat model of parkinsonism#417983
Record · ID 394663
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive